Neville E, Ellison G, Kiaris H, Stewart M, Spandidos D, Fox J, Field J
UNIV LIVERPOOL,DEPT CLIN DENT SCI,MOLEC GENET & ONCOL GRP,LIVERPOOL L69 3BX,MERSEYSIDE,ENGLAND. ZENECA DIAGNOST,RES & DEV GRP,NORTHWICH CW9 7RA,CHESHIRE,ENGLAND. NATL HELLEN RES FND,INST BIOL RES & BIOTECHNOL,GR-11635 ATHENS,GREECE. UNIV CRETE,SCH MED,GR-71110 IRAKLION,GREECE.
Int J Oncol. 1995 Sep;7(3):511-4. doi: 10.3892/ijo.7.3.511.
Forty-five non-small cell lung cancers (NSCLC) were examined for the presence of K-ras mutations in codon 12 using RFLP (restriction fragment length polymorphism) and ARMS (amplification refractory mutation system) assays. The RFLP analysis consisted of a PCR and subsequent digestion of the product with BstNI. Three adenocarcinomas and one adenosquamous carcinoma were shown to have mutations at codon 12. All of these samples were also examined using the ARMS assay for mutations at codon 12 and second base G to A transitions at codon 13 of the K-ras gene. The same four samples were confirmed to have a single base change in codon 12. No G to A transitions were found at codon 13. The four mutations were: one G to C transversion, one G to A transition and two G to T transversions. All mutations occurred at the second position of codon 12 as shown by the ARMS assay. Both of these techniques are rapid and reproducible for the identification of mutations in the K-ras gene and have potential for use in cancer diagnosis.
使用限制性片段长度多态性(RFLP)和扩增阻滞突变系统(ARMS)检测法,对45例非小细胞肺癌(NSCLC)进行第12密码子K-ras突变检测。RFLP分析包括PCR及随后用BstNI对产物进行酶切。结果显示3例腺癌和1例腺鳞癌在第12密码子处存在突变。所有这些样本也使用ARMS检测法检测K-ras基因第12密码子处的突变以及第13密码子处第二个碱基由G到A的转换。同样这4个样本被证实第12密码子存在单碱基改变。在第13密码子处未发现G到A的转换。这4个突变分别为:1个G到C的颠换、1个G到A的转换和2个G到T的颠换。ARMS检测法显示所有突变均发生在第12密码子的第二位。这两种技术对于K-ras基因突变的鉴定均快速且可重复,具有用于癌症诊断的潜力。